From hopeless to remission. CAR T-Cell Therapy is transforming outcomes for certain blood and marrow cancers. The modified immune cells turning the tide against multiple myeloma. We catch up with a survivor two years after his treatment.
Информация
- Подкаст
- Канал
- ЧастотаЕжедневно
- Опубликовано1 ноября 2024 г., 14:46 UTC
- Длительность36 мин.
- ОграниченияБез ненормативной лексики